Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Crinetics Pharmaceuticals Stock (NASDAQ: CRNX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	7.00 / 739.18K
Day Range	- - -
52 Wk Range	33.67 - 62.53
Market Cap	$5.00B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	6.87%
Days to Cover	10.46

Recent News

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

Neurocrine's Crenessity receives FDA approval as a groundbreaking adjunctive treatment for classic CAH, offering a novel approach to hormone regulation.

Vandana Singh

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit Therapeutics, Plug Power and XPeng Inc.

Lekha Gupta

Nvidia To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	7.00 / 739.18K
Day Range	- - -
52 Wk Range	33.67 - 62.53
Market Cap	$5.00B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	6.87%
Days to Cover	10.46

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Crinetics Pharmaceuticals (CRNX) stock?

You can purchase shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) through any online brokerage.

View our list of the best stock brokerages

Who are Crinetics Pharmaceuticals (CRNX) competitors?

Other companies in Crinetics Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Crinetics Pharmaceuticals (CRNX) stock?

Crinetics Pharmaceuticals has a consensus price target of $67.77.

What is the current price for Crinetics Pharmaceuticals (CRNX)?

The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $53.92 last updated December 26, 2024 at 4:00 PM EST.

Does Crinetics Pharmaceuticals (CRNX) pay a dividend?

There are no upcoming dividends for Crinetics Pharmaceuticals.

When is Crinetics Pharmaceuticals (NASDAQ:CRNX) reporting earnings?

Crinetics Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is Crinetics Pharmaceuticals (CRNX) going to split?

There is no upcoming split for Crinetics Pharmaceuticals.

What sector and industry does Crinetics Pharmaceuticals (CRNX) operate in?

Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals (CRNX) Forecast